A review on potential of PARP inhibitors in the treatment of prostate cancer

A review on potential of PARP inhibitors in the treatment of prostate cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Մատենագիտական մանրամասներ
Հիմնական հեղինակ:	Islam, Saidul
Այլ հեղինակներ:	Sharmin, Shahana
Ձևաչափ:	Թեզիս
Լեզու:	English
Հրապարակվել է:	Brac University 2022
Խորագրեր:	Prostate cancer Therapeutic approaches mCRPC PARP inhibitors Olaparib Cancer > Treatment Enzyme inhibitors > Therapeutic use Cancer > Gene therapy
Առցանց հասանելիություն:	http://hdl.handle.net/10361/17308

Նմանատիպ նյութեր

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
: Karim, Azrin
Հրապարակվել է: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
: Flora, Sanzida Alam
Հրապարակվել է: (2024)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
: Meem, Manila
Հրապարակվել է: (2023)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
: Alam, Tahera
Հրապարակվել է: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
: Jahan, Nusrat
Հրապարակվել է: (2024)

Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
: Ahmed, Nafisa
Հրապարակվել է: (2023)

Immunotherapy in the Management of Lung Cancer
: Tasnim, Humayra
Հրապարակվել է: (2022)

A review on triple-negative breast cancer and its potential treatment
: Niasa, Jannatul Ferdous
Հրապարակվել է: (2023)

Stem cells as therapeutic carrier in cancer treatment
: Anika, Mysha Yeasmin
Հրապարակվել է: (2022)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
: Hasan, Amit
Հրապարակվել է: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
: Chakraborty, Anuradha
Հրապարակվել է: (2024)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
: Khan, Muidul Hasan
Հրապարակվել է: (2024)

A review on potential role of cannabinoids as therapeutic agents in different types of cancer
: Roy, Hredita
Հրապարակվել է: (2018)

Recent advances in Cancer treatment targeting autophagy and future aspects
: Emon, Kamrul Hasan
Հրապարակվել է: (2022)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
: Mirza, Maisa Tasnim
Հրապարակվել է: (2023)

Role of toll-like receptors in cancer immunotherapy– a review
: Khan, Rezia Nowrin
Հրապարակվել է: (2021)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
: Nuha, Nabiha Tahsin
Հրապարակվել է: (2024)

Role of statins as antagonists of SPARC in gastric cancer
: Shahmat, Rad
Հրապարակվել է: (2019)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
: Sorno, Rubina Haque
Հրապարակվել է: (2024)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
: Ratu, Tabassum
Հրապարակվել է: (2024)

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
: Choki, Kinley
Հրապարակվել է: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
: Razna, Amrin Islam
Հրապարակվել է: (2019)

A comprehensive review on drug repurposing in cancer treatment
: Sarkar, Onusree
Հրապարակվել է: (2024)

A review on RNAi technology and its therapeutic potential in Cancer
: Mahaleka, Aarshi
Հրապարակվել է: (2024)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
: Shaikat, Mahdi Mubin
Հրապարակվել է: (2023)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
: Hasan, Sakib
Հրապարակվել է: (2024)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
: Nawar, Anika
Հրապարակվել է: (2019)

Statistics and informatics in molecular cancer research

Identification of FAP inhibitors using in silico simulation study
: Deeba, Maliha Tasnim
Հրապարակվել է: (2018)

Targeting BRAFV600E in the treatment of CRC
: Roja, Mashwiyat Samrin
Հրապարակվել է: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
: Alam, Kazi Tasnuva
Հրապարակվել է: (2022)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
: Rahman, Sanjida
Հրապարակվել է: (2024)

Biosimilar in lymphoma treatment
: Tanisha, Mehrin Haque
Հրապարակվել է: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
: Khondokar, Faiza
Հրապարակվել է: (2022)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
: Islam, Nahidul
Հրապարակվել է: (2023)

A review on Single Nucleotide Polymorphism (SNPs) and their effect on cancer risk in South Asian population
: Beruni, Sajid Mahmud Al
Հրապարակվել է: (2022)

Oncogenes: new targets in cancer treatment
: Chowdhury, Waseka Shams
Հրապարակվել է: (2020)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
: Muntaha, Habibatul
Հրապարակվել է: (2023)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
: Haque, Mushfiqul
Հրապարակվել է: (2019)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
: Karim, Samia Binte
Հրապարակվել է: (2024)